NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (trial in progress) Meeting Abstract
| Authors: | Baldini, C.; Patnaik, A.; Lakhani, N.; Call, J.; Galsky, M.; Garmezy, B.; Wei, A.; Carter, L.; Powles, T.; Siefker-Radtke, A.; O'Donnell, P. H.; Kitano, S.; Castellano, D. E.; Shinde, R.; Joshua, A. M.; Balbas, M.; Han, H.; Chang, A. E.; Gao, X.; Iyer, G. |
| Abstract Title: | NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (trial in progress) |
| Meeting Title: | 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 211 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 23-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S66 |
| Language: | English |
| ACCESSION: | WOS:001345547300158 |
| DOI: | 10.1016/j.ejca.2024.114686 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 165 (PB153) -- Article number: 114686 -- Source: Wos |
